SII Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
AWA
MCM
RJA
SII Investments's IHE Position: Q1 2018 in Review
SII Investments sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2018, closing a stake of 23,028 shares — an estimated $1.18M sold.
SII Investments first reported a position in IHE in Q2 2013 and held it in 18 quarters. The position peaked at $1.42M in Q3 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2018.
- SII Investments reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
- SII Investments sold 23,028 iShares US Pharmaceuticals ETF shares in Q1 2018, an estimated $1.18M.
- SII Investments first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 18 quarters.
- SII Investments's iShares US Pharmaceuticals ETF position peaked at $1.42M in Q3 2017.
- 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2018.
Based on SII Investments's 13F filing for Q1 2018.